From: Analysis of genetic copy number changes in cervical disease progression
 | % of Samples with Probe Copy Gains |  | % of Samples with Probe Copy Loss | ||||
---|---|---|---|---|---|---|---|
Probe | CINa1 | CINa2-3 | SCCb | Probe | CINa1 | CINa2-3 | SCCb |
8q24 | 0 | 80 | 100 | 3p14.2 | 20 | 20 | 80 |
3q26 | 30 | 80 | 100 | 2q33-q34 | 11 | 11 | 20 |
5p13 | 30 | 80 | 100 | Xq11-q12 | 22 | 0 | 20 |
5p15.2 | 40 | 80 | 100 | 3p21-p23 | 11 | 0 | 18 |
CEPc8 | 30 | 78 | 100 | Xp22.3 | 20 | 0 | 11 |
CEPcX | 50 | 75 | 100 | 1q41 | 0 | 0 | 10 |
CEPc10 | 18 | 70 | 100 | 7p12.3-p12.1 | 0 | 0 | 10 |
CEPc16 | 20 | 60 | 100 | CEPc7 | 10 | 0 | 10 |
CEPc12 | 10 | 56 | 100 | 2q23-q37 | 0 | 10 | 0 |
CEPc6 | 10 | 50 | 100 | 6q16.3-q21.3 | 0 | 10 | 0 |
CEPc9 | 0 | 44 | 100 | 6p21.2 | 10 | 10 | 0 |
CEPc11 | 20 | 44 | 100 | 8q24.12-24.13 | 0 | 0 | 0 |
CEPc1 | 13 | 43 | 100 | CEPc16 | 0 | 0 | 0 |
CEPc17 | 10 | 40 | 100 | 20q13.2-q13.3 | 0 | 0 | 0 |
CEPc7 | 30 | 60 | 91 | CEPc15 | 0 | 0 | 0 |
20q13.2-q13.3 | 10 | 80 | 90 | 2p24.1 | 0 | 0 | 0 |
CEPc15 | 0 | 70 | 90 | CEPc18 | 0 | 0 | 0 |
2p24.1 | 20 | 67 | 90 | 11p15.5 | 0 | 0 | 0 |
1q41 | 9 | 60 | 90 | 11q13 | 0 | 0 | 0 |
7p12.3-p12.1 | 10 | 60 | 90 | 1p31.1.1 | 0 | 0 | 0 |
Xq11-q12 | 11 | 60 | 90 | 4p16.3 | 0 | 0 | 0 |
CEPc18 | 11 | 60 | 90 | 11q23 | 0 | 0 | 0 |
11q13 | 27 | 60 | 90 | 4p15.3 | 0 | 0 | 0 |
11p15.5 | 18 | 50 | 90 | 3q26 | 10 | 0 | 0 |
11p23 | 45 | 30 | 90 | 5p13 | 10 | 0 | 0 |
6q16.3-q21.3 | 10 | 40 | 82 | 5p15.2 | 10 | 0 | 0 |
6p21.2 | 0 | 10 | 82 | CEPc8 | 10 | 0 | 0 |
Xp22.3 | 0 | 70 | 80 | CEPcX | 10 | 0 | 0 |
1p31.1.1 | 9 | 70 | 80 | CEPc12 | 10 | 0 | 0 |
4p15.3 | 20 | 50 | 80 | CEPc11 | 10 | 0 | 0 |
4p16.3 | 30 | 50 | 80 | CEPc9 | 10 | 0 | 0 |
2q23-q37 | 20 | 30 | 80 | CEPc17 | 10 | 0 | 0 |
3p21-p23 | 14 | 86 | 55 | CEPc6 | 10 | 0 | 0 |
2q33-q34 | 33 | 44 | 50 | CEPc1 | 13 | 0 | 0 |
3p14.2 | 10 | 60 | 9 | CEPc10 | 18 | 0 | 0 |